At Penn Medicine, our program has grown in response to the devastating impact of opioid use in our vulnerable community. Yet, based on electronic medical record data, fewer than 20% of patients receive MOUDs while admitted to the hospital, and there are treatment needs in our community that are not addressed by our outpatient clinics. Now is the time to expand provider readiness and equity in treating OUD by preparing our clinical staff at Penn Medicine to provide comprehensive addiction care with a strong emphasis on MOUD – buprenorphine. This training is an adaptation of the X-waiver training and will focus on the proper administration of buprenorphine, patient counseling, harm reduction and pharmacology.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 3400 Civic Center Blvd, Building 4
Pricing
CME included with membership
| Physician / Industry Attendee (In-Person) | $90 |
| NP / PA / Other Healthcare Professional (In-Person) | $75 |
| Resident / Fellow / Student / Penn Medicine Employee (In-Person) | Free |
| Virtual (Live-Stream) US-Based Attendee | $75 |
| Virtual (Live-Stream) International Attendee (first 1,000) | Free |
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Clinician Wellness & Burnout
- Communication & Shared Decision-Making
- Comprehensive & Board Review
- Critical Care Medicine
- Emergency Medicine
- Family Medicine
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Hospital Medicine
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Neurology
- Trauma Surgery
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Internal Medicine
- Neurology
- Oncology & Hematology
- Pediatrics
- Primary care
- Psychiatry
- No reviews yet. Be the first to share yours.



